KRAS and adenocarcinoma: Interestingly, the Kras mutational activation effect that is exerted by Myc overexpression [86] was not observed in adenocarcinoma tumors resulting from Notch1ICD/Myc cooperation [13], clearly indicating that Notch1 can substitute for Kras activation in Myc-driven tumorigenesis.